GATA3 and breast cancer: In accordance with the molecular findings with regard to GATA3 gene hypermethylation, immunoreactivity for GATA3 was constantly reduced (cases 2, 4, 5, and 7) or completely missing in all MGA lesions (cases 1, 3, 6, and 8) and adjacent BC (Table 3 and Figure 6C).